The aim of this audit was to evaluate the effect of the introduction of biochemical screening for Downs syndrome (triple test i.e., serum alphafetoprotein [AFP], human chorionic gonadotrophin [hCG], and unconjugated oestriol [uE3] on amniocentesis at Whipps Cross Hospital.